ILMNNasdaqLaboratory Analytical InstrumentsFiscal year ends January 3

ILLUMINA, INC.

Financials through Q2 FY2026, quarter ended Jun 28, 2026Last filing: 10-Q on Jul 31, 2026

$262.66+0.12 (+0.05%)

Close on Oct 19, 2026

Market cap: $40.19B
P/E (TTM): 48.8
Dividend yield: –

Dividends

Illumina has not reported a dividend

No dividend per share appears in Illumina's annual filings since fiscal 2010.

Where these numbers come from

Parsed from the XBRL in Illumina's annual and quarterly filings with the SEC
Per-share figures adjusted for the 2-for-1 split on Sep 23, 2008
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Against peers

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is ILMN.

Revenue growth4.9% · median 4.1%

Gross margin66.4% · median 52.9%

Operating margin19.6% · median 7.2%

Net margin18.4% · median 8.6%

Company	Revenue	Growth
A	$7.37B	+8.6%
ILMN	$4.49B	+4.9%
MTD	$4.13B	+6.9%
BRKR	$3.50B	+1.6%
RVTY	$2.91B	+4.1%
BIO	$2.59B	+1.4%

Company

Next earnings (est.): Oct 29, 2026, after close
Exchange: Nasdaq
Industry: Laboratory Analytical Instruments
Fiscal year ends: January 3
Employees: 52
Held by institutions: 100.0%
Auditor: Ernst & Young LLP
SEC CIK: 1110803

Advertisement
300 × 250